Publications

  1. Sinicrope FA, Dudeja PK, Bissonnette BM, Safa AR, Brasitus TA. Modulation of P- glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J Biol Chem. 1992; 267:24995-5002.
    View PubMed
  2. Sinicrope FA, Levin B. Gastric cancer. Curr Opin in Gastroenterol. 1993; 9:930-7.
  3. Kavin H, Sinicrope FA, Esker AH. Perforation of the colon at endoscopy: a review. Am J Gastroenterology. 1992; 87:161-7.
  4. Sinicrope FA, Hart J, Michelassi F, Safa AR, Lee JJ, Brasitus TA. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer. 1994; 74:2908-17.
    View PubMed
  5. Sinicrope FA, Levin B. Gastric cancer. Curr Opin in Gastroenterol. 1994; 10:610-17.
  6. Sinicrope FA, Sugarman SM. Adjuvant therapy of colon carcinoma: current status and future directions. Cancer Bull. 1994; 46:344-51.
  7. Sinicrope FA, Ruan S, Cleary KR, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995; 55:237-41.
    View PubMed
  8. Sinicrope FA, Sugarman S. Role of adjuvant therapy in surgically resected colorectal carcinoma. Gastroenterology. 1995; 109:984-93.
    View PubMed
  9. Weber D, Dimopoulos M, Sinicrope FA, Alexanian R. VAD-cyclosporin therapy for VAD-resistant multiple myeloma. Leuk Lymphoma. 1995; 19:159-63.
    View PubMed
  10. Sinicrope FA, Hart J, Michelassi FM, Lee JJ. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin Cancer Res. 1995; 1:1103-10.
    View PubMed
  11. Sinicrope FA, Evans DB, Leach S, Cleary KR, Rich TA, Fenoglio C, Lee JJ, Abbruzzese JL. Bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. Clin Cancer Res. 1996; 2:2015-22.
    View PubMed
  12. Sinicrope FA, Pazdur R, Levin B. Phase I evaluation of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy of colon carcinoma. Clin Cancer Res. 1996; 2:37-41.
    View PubMed
  13. Al-Sabbagh R, Sinicrope FA, Sellin J, Roubein L. Short-chain fatty acid enemas: treatment of radiation proctitis. Am J Gastroenterol. 1996; 91:1814-16.
    View PubMed
  14. Roubein LD, Lynch PM, Glober G, Sinicrope FA. Interobserver variability in endoscopic ultrasonography: a prospective evaluation. Gastrointest Endosc. 1996; 5:573-7.
  15. Sinicrope FA, Roddey GR, LeMoine M, Frazier M, Stephens LC, Shen Y, Zhang W. Loss of p21WAF1/Cip1 protein expression accompanies neoplastic progression in the sporadic colorectal cancers but not HNPCCs. Clin Cancer Res. 1998; 4:1251-61.
    View PubMed
  16. Frazier ML, Sinicrope FA, Amos CI, Cleary KR, Lynch PM, Luthra R. Loci for efficient detection of microsatellite instability in hereditary nonpolyposis colorectal cancer. Oncology Reports. 1999; 6:497-505.
    View PubMed
  17. Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Chiao PJ, Abbruzzese JL, Evans DB. Prognostic factors in resectable pancreatic cancer: P53 and bcl-2. J Gastrointest Surg. 1999; 3:263-77.
    View PubMed
  18. Sinicrope FA, Hart J, Lemoine M, Michelassi F, Lee JJ, Stephens LC. Apoptotic and mitotic indices predict patient survival rates in lymph node-negative colon carcinomas. Clin Cancer Res. 1999; 5:1793-804.
    View PubMed
  19. Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML. Reduced expression of cyclooxygenase-2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology. 1999; 117:350-8.
    View PubMed
  20. Molina M, Anja-Buta M, Lemoine M, Xi L, Frazier M, Sinicrope FA. Increased cyclooxygenase-2 expression in pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 1999; 59:4356-62.
    View PubMed
  21. Boland CR, Sinicrope FA, Brenner D, Carethers J. Colorectal cancer prevention and treatment. Gastroenterology. 2000; 118:S115-S28.
    View PubMed
  22. Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa J-P. Aberrant methylation of the COX-2 CpG island in colorectal tumors. Cancer Res. 2000; 60:4044-8.
    View PubMed
  23. Sinicrope FA, Gwyn K. Chemoprevention of colorectal cancer. Am J Gastroenterol. 2002; 97:13-21.
    View PubMed
  24. Tatabe S, Unate H, Sinicrope FA, Sakatani T, Sugamura K, Makino M, Ito H, Savaraj N, Kaibara N, Kuo MT. Expression of heavy subunit of y-Glutamylcysteine synthetase (y-GCSh) in human colorectal carcinoma. Int J Cancer. 2002; 97:21-7.
    View PubMed
  25. Sample D, Sinicrope PS, Wargovich MJ, Sinicrope FA. Post study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2002; 11:281-5.
    View PubMed
  26. Sample D, Wargovich MJ, Fischer SM, Inamdar N, Schwartz P, Wang X, Do, K-A, Sinicrope FA. A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal PGE2 levels as a biomarker. Cancer Epidemiol Biomarkers Prev. 2002; 11:275-9.
    View PubMed
  27. Tatabe S, Sinicrope FA, Kuo MT. Induction of multidrug resistance protein MRP1and MRP3 and y-glutamylcystein synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun. 2002; 290:1427-33.
    View PubMed
  28. Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 2002; 62:1676-81.
    View PubMed
  29. Bismar MM, Sinicrope FA. Radiation enteritis. Curr Gastroenterol Rep. 2002 Oct; 4(5):361-5.
    View PubMed
  30. Sinicrope FA, Roddey GR, McDonnell TJ, Shen Y, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 1996 06. 1999-20; 2:1999-2006.
  31. Tang XM, Sun YJ, Half E, Kuo MT, Sinicrope F. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res. 2002 Sep 1; 62(17):4903-8.
    View PubMed
  32. Sun YJ, Tang XM, Half E, Kuo MT, Sinicrope FA. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 2002 Nov 1; 62(21):6323-8.
    View PubMed
  33. Half E, Broaddus R, Danenberg KD, Danenberg PV, Ayers GD, Sinicrope FA. HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. Int J Cancer. 2004 Feb 10; 108(4):540-8.
    View PubMed
  34. Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Reviews. 2004 Jan-Jun; 23(1-2):63-75.
    View PubMed
  35. Wargovich MJ, Chang P, Velasco M, Sinicrope F, Eisenbrodt E, Sellin J. Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci. Appl Immunohistochem Mol Morphol. 2004 Dec; 12(4):350-5.
    View PubMed
  36. Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Semin Oncol. 2005 Feb; 32(1):24-34.
    View PubMed
  37. Sinicrope FA, Penington RC. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol Cancer Ther. 2005 Oct; 4(10):1475-83.
    View PubMed
  38. Alberts SR, Sinicrope FA, Grothey A. N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer. Clin Colorectal Cancer. 2005 Sep; 5(3):211-3.
    View PubMed
  39. Yeung BH, Huang DC, Sinicrope FA. PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells. J Biol Chem. 2006 Apr 28; 281(17):11923-32. Epub 2006 Jan 30.
    View PubMed
  40. Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN. Thymidylate synthase expression in colon carcinomas with microsatellite instability. Clin Cancer Res 2006 May 1; 12 (9):2738-44
    View PubMed
  41. Cohen G, Mustafi R, Chumsangsri A, Little N, Nathanson J, Cerda S, Jagadeeswaran S, Dougherty U, Joseph L, Hart J, Yerian L, Tretiakova M, Yuan W, Obara P, Khare S, Sinicrope FA, Fichera A, Boss GR, Carroll R, Bissonnette M. Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. Cancer Res. 2006 Jun 1; 66(11):5656-64.
    View PubMed
  42. Sinicrope FA. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog. 2006 Jun; 45(6):447-54.
    View PubMed
  43. Bernold DM, Sinicrope FA. Advances in chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol. 2006 Jul; 4(7):808-21. Epub 2006 Jun 22.
    View PubMed
  44. Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006 Sep; 131 (3):729-37
    View PubMed
  45. Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 2006 Dec; 101 (12):2818-25 Epub 2006 Oct 06
    View PubMed
  46. Sinicrope FA , Rego RL , Garrity-Park MM , Foster NR , Sargent DJ , Goldberg RM , Wiesenfeld M , Witzig TE , Thibodeau SN , Burgart LJ . Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability. Int J Cancer 2007 Mar 15; 120 (6):1232-8
    View PubMed
  47. Half E, Sun Y, Sinicrope FA. Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells. Cancer Lett. 2007 Jun 28; 251(2):237-46. Epub 2006 Dec 26.
    View PubMed
  48. Huang S, Sinicrope FA. BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells. Cancer Res. 2008 Apr 15; 68(8):2944-51.
    View PubMed
  49. Sinicrope FA, Rego RL, Foster NR, Thibodeau SN, Alberts SR, Windschitl HE, Sargent DJ. Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers. Clin Cancer Res. 2008 Jul 1; 14(13):4128-33.
    View PubMed
  50. Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus. 2008; 21(3):241-50.
    View PubMed
  51. Sinicrope FA, Rego RL, Okumura K, Foster NR, O'Connell MJ, Sargent DJ, Windschitl HE. Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Clin Cancer Res. 2008 Sep 15; 14(18):5810-8.
    View PubMed
  52. Okumura K, Huang S, Sinicrope FA. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737. Clin Cancer Res. 2008 Dec 15; 14(24):8132-42.
    View PubMed
  53. Huang S, Okumura K, Sinicrope FA. BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells. Clin Cancer Res. 2009 Jan 1; 15(1):150-9.
    View PubMed
  54. Sinicrope FA, Sargent DJ. Clinical implications of microsatellite instability in sporadic colon cancers. Curr Opin Oncol. 2009 Jul; 21(4):369-73.
    View PubMed
  55. Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology. 2009 Oct; 137(4):1270-9. Epub 2009 Jul 03.
    View PubMed
  56. Rego RL, Foster NR, Smyrk TC, Le M, O'Connell MJ, Sargent DJ, Windschitl H, Sinicrope FA. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer. 2010 Jan 5; 102(1):165-72. Epub 2009 Dec 08.
    View PubMed
  57. Sun Y, Sinicrope FA. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells. Mol Cancer Ther. 2005 Jan; 4(1):51-9.
    View PubMed
  58. Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC, Familial Adenomatous Polyposis Study Group. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):920-7.
    View PubMed
  59. Huang S, Sinicrope FA. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy. 2010 Feb; 6(2):256-69. Epub 2010 Feb 06.
    View PubMed
  60. Smoot RL, Blechacz BR, Werneburg NW, Bronk SF, Sinicrope FA, Sirica AE, Gores GJ. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells. Cancer Res. 2010 Mar 1; 70(5):1960-9. Epub 2010 Feb 16.
    View PubMed
  61. Sinicrope FA. DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat Rev Clin Oncol. 2010 Mar; 7(3):174-7.
    View PubMed
  62. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010 Mar 15; 16(6):1884-93. Epub 2010 Mar 09.
    View PubMed
  63. Huang S, Sinicrope FA. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol Cancer Ther. 2010 Mar; 9(3):742-50. Epub 2010 Mar 02.
    View PubMed
  64. Sinicrope FA. Opinion: DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat Rev Clin Oncol. 2010 Mar; 7(3):174-7.
    View PubMed
  65. Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010 Jul 10; 28(20):3219-26. Epub 2010 May 24.
    View PubMed
  66. Chee CE, Sinicrope FA. Targeted therapeutic agents for colorectal cancer. Gastroenterol Clin North Am. 2010 Sep; 39(3):601-13.
    View PubMed
  67. Yang ZJ, Chee CE, Huang S, Sinicrope F. Autophagy modulation for cancer therapy. Cancer Biol Ther. 2011 Jan 15; 11(2):169-76.
    View PubMed
  68. Sugumar A, Sinicrope FA. Serrated polyps of the colon. F1000 Med Rep. 2010; 2:89. Epub 2010 Dec 17.
    View PubMed
  69. Sinicrope FA, Yang ZJ. Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer. Future Oncol. 2011 Mar; 7(3):467-74.
    View PubMed
  70. Masuoka HC, Sinicrope FA. Clinical relevance of apoptotic regulatory proteins in colorectal cancers. Current Colorectal Cancer Reports. 2010; 6(3):111-7.
  71. Sinicrope FA, Broaddus R, Joshi N, Gerner E, Half E, Kirsch I, Lewin J, Morlan B, Hong WK. Evaluation of difluoromethylornithine for the chemoprevention of Barrett's esophagus and mucosal dysplasia. Cancer Prev Res (Phila). 2011 Jun; 4(6):829-39.
    View PubMed
  72. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011 Sep; 10(9):1533-41. Epub 2011 Aug 30.
    View PubMed
  73. Huang S, Yang ZJ, Yu C, Sinicrope FA. Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1. J Biol Chem. 2011 Nov 18; 286(46):40002-12. Epub 2011 Sep 23.
    View PubMed
  74. Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope FA. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011 Dec 1; 29(34):4561-7. Epub 2011 Oct 11.
    View PubMed
  75. Winawer SJ, Pasricha PJ, Schmiegel W, Sinicrope FA, Sung J, Seufferlein T, Kassem AM, Malekzadeh R, Kurtz RC, Classen M, Tytgat GN. The future role of the gastroenterologist in digestive oncology: an international perspective. Gastroenterology. 2011 Oct; 141(4):e13-21. Epub 2011 Aug 24.
    View PubMed
  76. Sinicrope PS, Goode EL, Limburg PJ, Vernon SW, Wick JB, Patten CA, Decker PA, Hanson AC, Smith CM, Beebe TJ, Sinicrope FA, Lindor NM, Brockman TA, Melton LJ, Petersen GM. A population-based study of prevalence and adherence trends in average risk colorectal cancer screening, 1997 to 2008. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):347-50. Epub 2011 Dec 05.
    View PubMed
  77. Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C, Moore MJ, Gallinger S, Sargent DJ. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011 Jun 8; 103(11):863-75. Epub 2011 May 19.
    View PubMed
  78. Sinicrope FA, Foster NR, Yoon HH, Smyrk TC, Kim GP, Allegra CJ, Yothers G, Nikcevich DA, Sargent DJ. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol. 2012 Feb 1; 30(4):406-12. Epub 2011 Dec 27.
    View PubMed
  79. Yoon HH, Shi Q, Sukov WR, Wiktor AE, Khan M, Sattler CA, Grothey A, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res. 2012 Jan 15; 18(2):546-54.
    View PubMed
  80. Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res. 2012 Mar 15; 18(6):1506-12. Epub 2012 Feb 02.
    View PubMed
  81. Alberts SR, Sargent DJ, Nair S, Mahoney MR, Mooney M, Thibodeau SN, Smyrk TC, Sinicrope FA, Chan E, Gill S, Kahlenberg MS, Shields AF, Quesenberry JT, Webb TA, Farr GH Jr, Pockaj BA, Grothey A, Goldberg RM. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA. 2012 Apr 4; 307(13):1383-93.
    View PubMed
  82. Yoon HH, Orrock JM, Foster NR, Sargent DJ, Smyrk TC, Sinicrope FA. Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas. PLoS One. 2012; 7(8):e42274. Epub 2012 Aug 06.
    View PubMed
  83. Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. J Clin Oncol. 2012 Nov 10; 30(32):3932-8. Epub 2012 Sep 17.
    View PubMed
  84. Sinicrope FA, Penington RC, Tang XM. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Clin Cancer Res. 2004 Dec 15; 10(24):8284-92.
    View PubMed
  85. Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol. 2013 Jul; 11(7):760-7; quiz e54-5. Epub 2012 Dec 23.
    View PubMed
  86. Stanton MJ, Dutta S, Zhang H, Polavaram NS, Leontovich AA, Honscheid P, Sinicrope FA, Tindall DJ, Muders MH, Datta K. Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance. Cancer Res. 2013 Jan 1; 73(1):160-71. Epub 2012 Nov 13.
    View PubMed
  87. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, Goldberg RM, Degramont A, O'Connell MJ, Sargent DJ, Adjuvant Colon. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013 Apr 15; 119(8):1528-36. Epub 2013 Jan 10.
    View PubMed
  88. Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010 Dec; 85(12):1080-9.
    View PubMed
  89. Half E, Sinicrope FA. Current status of colorectal cancer chemoprevention. Current Colorectal Cancer Reports. 2007; 3(1):39-48.
  90. Galon J, Pages F, Marincola FM, Angell HK, Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, Tatangelo F, Britten CM, Kreiter S, Chouchane L, Delrio P, Arndt H, Asslaber M, Maio M, Masucci GV, Mihm M, Vidal-Vanaclocha F, Allison JP, Gnjatic S, Hakansson L, Huber C, Singh-Jasuja H, Ottensmeier C, Zwierzina H, Laghi L, Grizzi F, Ohashi PS, Shaw PA, Clarke BA, Wouters BG, Kawakami Y, Hazama S, Okuno K, Wang E, O'Donnell-Tormey J, Lagorce C, Pawelec G, Nishimura MI, Hawkins R, Lapointe R, Lundqvist A, Khleif SN, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Palmqvist R, Nagtegaal ID, Wang Y, D'Arrigo C, Kopetz S, Sinicrope FA, Trinchieri G, Gajewski TF, Ascierto PA, Fox BA. Hakansson L, Huber C, Singh-Jasuja H, Ottensmeier C, Zwierzina H, Laghi L, Grizzi F, Ohashi PS, Shaw PA, Clarke BA, Wouters BG, Kawakami Y, Hazama S, Okuno K, Wang E, O'Donnell-Tormey J, Lagorce C, Pawelec G, Nishimura MI, Hawkins R, Lapointe R, et al. Cancer classification using the Immunoscore: a worldwide task force. J Transl Med. 2012; 10:205. Epub 2012 Oct 03.
    View PubMed
  91. Sinicrope FA, Smyrk TC, Tougeron D, Thibodeau SN, Singh S, Muranyi A, Shanmugam K, Grogan TM, Alberts SR, Shi Q. Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas. Cancer. 2013 Aug 1; 119(15):2765-70. Epub 2013 May 08.
    View PubMed
  92. Park JM, Huang S, Tougeron D, Sinicrope FA. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. PLoS One. 2013; 8(5):e65369. Epub 2013 May 28.
    View PubMed
  93. Sinicrope FA , Mahoney MR , Smyrk TC , Thibodeau SN , Warren RS , Bertagnolli MM , Nelson GD , Goldberg RM , Sargent DJ , Alberts SR . Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy. J Clin Oncol 2013 Oct 10; 31 (29):3664-72 Epub 2013 Sept 09
    View PubMed
  94. Huang S, Okamoto K, Yu C, Sinicrope FA. p62/sequestosome-1 up-regulation promotes ABT-263-induced caspase-8 aggregation/activation on the autophagosome. J Biol Chem. 2013 Nov 22; 288(47):33654-66. Epub 2013 Oct 11.
    View PubMed
  95. Tougeron D, Sha D, Manthravadi S, Sinicrope FA. Aspirin and colorectal cancer: back to the future. Clin Cancer Res. 2014 Mar 1; 20(5):1087-94. Epub 2013 Dec 10.
    View PubMed
  96. et al , Klionsky DJ , Abdalla FC , Abeliovich H , Abraham RT , Acevedo-Arozena A , Adeli K , Agholme L , Agnello M , Agostinis P , Aguirre-Ghiso JA , et al, Ahn HJ , Ait-Mohamed O , Ait-Si-Ali S , Akematsu T , Akira S , Al-Younes HM , Al-Zeer MA , Albert ML , Albin RL , Alegre-Abarrategui J , Aleo MF , Alirezaei M , Almasan A , Almonte-Becerril M , Amano A , Amaravadi R , Amarnath S , Amer AO , Andrieu-Abadie N , Anantharam V , Ann DK , Anoopkumar-Dukie S , Aoki H , Apostolova N , Arancia G , Aris JP , Asanuma K , Asare NY , Ashida H , Askanas V , Askew DS , Auberger P , Baba M , Backues SK , Baehrecke EH , Bahr BA , Bai XY , Bailly Y , Baiocchi R , Baldini G , Balduini W , Ballabio A , Bamber BA , Bampton ET , Banhegyi G , Bartholomew CR , Bassham DC , Bast RC Jr, Batoko H , Bay BH , Beau I , Bechet DM , Begley TJ , Behl C , Behrends C , Bekri S , Bellaire B , Bendall LJ , Benetti L , Berliocchi L , Bernardi H , Bernassola F , Besteiro S , Bhatia-Kissova I , Bi X , Biard-Piechaczyk M , Blum JS , Boise LH , Bonaldo P , Boone DL , Bornhauser BC , Bortoluci KR , Bossis I , Bost F , Bourquin JP , Boya P , Boyer-Guittaut M , Bozhkov PV , Brady NR , Brancolini C , Brech A , Brenman JE , Brennand A , Bresnick EH , Brest P , Bridges D , Bristol ML , Brookes PS , Brown EJ , Brumell JH , Brunetti-Pierri N , Brunk UT , Bulman DE , Bultman SJ , Bultynck G , Burbulla LF , Bursch W , Butchar JP , Buzgariu W , Bydlowski SP , Cadwell K , Cahova M , Cai D , Cai J , Cai Q , Calabretta B , Calvo-Garrido J , Camougrand N , Campanella M , Campos-Salinas J , Candi E , Cao L , Caplan AB , Carding SR , Cardoso SM , Carew JS , Carlin CR , Carmignac V , Carneiro LA , Carra S , Caruso RA , Casari G , Casas C , Castino R , Cebollero E , Cecconi F , Celli J , Chaachouay H , Chae HJ , Chai CY , Chan DC , Chan EY , Chang RC , Che CM , Chen CC , Chen GC , Chen GC , Chen M , Chen Q , Chen SS , Chen W , Chen X , Chen X , Chen X , Chen YG , Chen YG , Chen YG , Chen YG , Chen Z , Cheng A , Cheng CH , Cheng Y , Cheong H , Cheong JH , Cherry S , Chess-Williams R , Cheung ZH , Chevet E , Chiang HL , Chiarelli R , Chiba T , Chin LS , Chiou SH , Chisari FV , Cho CH , Cho DH , Choi AM , Choi D , Choi KS , Choi ME , Chouaib S , Choubey D , Choubey V , Chu CT , Chuang TH , Chueh SH , Chun T , Chwae YJ , Chye ML , Ciarcia R , Ciriolo MR , Clague MJ , Clark RS , Clarke PG , Clarke R , Codogno P , Coller HA , Colombo MI , Comincini S , Condello M , Condorelli F , Cookson MR , Coombs GH , Coppens I , Corbalan R , Cossart P , Costelli P , Costes S , Coto-Montes A , Couve E , Coxon FP , Cregg JM , Crespo JL , Cronje MJ , Cuervo AM , Cullen JJ , Czaja MJ , D'Amelio M , Darfeuille-Michaud A , Davids LM , Davies FE , De Felici M , de Groot JF , de Haan CA , De Martino L , De Milito A , De Tata V , Debnath J , Degterev A , Dehay B , Delbridge LM , Demarchi F , Deng YZ , Dengjel J , Dent P , Denton D , Deretic V , Desai SD , Ding WX , Dong Z , Feng Y , Finley KD , Fisher EA , Fox HS , Gao FB , Gao GF , Gonzalez CD , Hansen M , Harris AL , Harris J , Hill JA , Huang J , Hurley JB , Hussain SN . J, Aleo MF, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, Amaravadi R, Amarnath S, Amer AO, Andrieu-Abadie N, Anantharam V, Ann DK, Anoopkumar-Dukie S, Aoki H, Apostolova N, Arancia G, Aris JP, Asanuma K, Asare NY, Ashida H, Askanas V, Askew DS, A Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 Apr; 8 (4):445-544
    View PubMed
  97. Ding H, McDonald JS, Yun S, Schneider PA, Peterson KL, Flatten KS, Loegering DA, Oberg AL, Riska SM, Huang S, Sinicrope FA, Adjei AA, Karp JE, Meng XW, Kaufmann SH. Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells. Haematologica. 2014 Jan; 99(1):60-9. Epub 2013 Aug 30.
    View PubMed
  98. Yoon HH, Sukov WR, Shi Q, Sattler CA, Wiktor AE, Diasio RB, Wu TT, Jenkins RB, Sinicrope FA. HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma. Cancer. 2014 Feb 1; 120(3):415-24. Epub 2013 Oct 21.
    View PubMed
  99. Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, Nagtegaal ID, Palmqvist R, Masucci GV, Botti G, Tatangelo F, Delrio P, Maio M, Laghi L, Grizzi F, Asslaber M, D'Arrigo C, Vidal-Vanaclocha F, Zavadova E, Chouchane L, Ohashi PS, Hafezi-Bakhtiari S, Wouters BG, Roehrl M, Nguyen L, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Wang Y, Kopetz S, Sinicrope FA, Scripcariu V, Ascierto PA, Marincola FM, Fox BA, Pages F. E, Chouchane L, Ohashi PS, Hafezi-Bakhtiari S, Wouters BG, Roehrl M, Nguyen L, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Wang Y, Kopetz S, Sinicrope FA, Scripcariu V, Ascierto PA, Marincola Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol. 2014 Jan; 232(2):199-209.
    View PubMed
  100. Alliance for Clinical Trials in Oncology, Huang J, Nair SG, Mahoney MR, Nelson GD, Shields AF, Chan E, Goldberg RM, Gill S, Kahlenberg MS, Quesenberry JT, Thibodeau SN, Smyrk TC, Grothey A, Sinicrope FA, Webb TA, Farr GH Jr, Pockaj BA, Berenberg JL, Mooney M, Sargent DJ, Alberts SR. Clinical Trials in Oncology. Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147. Clin Colorectal Cancer 2014 Jun; 13 (2):100-9 Epub 2013 Dec 28
    View PubMed
  101. Sha D, Lee AM, Shi Q, Alberts SR, Sargent DJ, Sinicrope FA, Diasio RB. Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial). Clin Cancer Res. 2014 Jun 15; 20(12):3319-27. Epub 2014 Apr 11.
    View PubMed
  102. Yoon HH, Tougeron D, Shi Q, Alberts SR, Mahoney MR, Nelson GD, Nair SG, Thibodeau SN, Goldberg RM, Sargent DJ, Sinicrope FA, Alliance for Clinical Trials in Oncology. KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance). Clin Cancer Res. 2014 Jun 1; 20(11):3033-43. Epub 2014 Mar 31.
    View PubMed
  103. Graves KD, Sinicrope PS, Esplen MJ, Peterson SK, Patten CA, Lowery J, Sinicrope FA, Nigon SK, Borgen J, Gorin SS, Keogh LA, Lindor NM. Communication of genetic test results to family and health-care providers following disclosure of research results. Genet Med. 2014; 16(4):294-301.
    View PubMed
  104. Alliance for Clinical Trials in Oncology, Gonsalves WI, Mahoney MR, Sargent DJ, Nelson GD, Alberts SR, Sinicrope FA, Goldberg RM, Limburg PJ, Thibodeau SN, Grothey A, Hubbard JM, Chan E, Nair S, Berenberg JL, McWilliams RR. Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147. J Natl Cancer Inst 2014 Jul; 106 (7) Epub 2014 June 12
    View PubMed
  105. Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther. 2013 Feb; 14(2):100-7. Epub 2012 Nov 28
    View PubMed
  106. Park JM, Tougeron D, Huang S, Okamoto K, Sinicrope FA. Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cells. PLoS One. 2014; 9(6):e100819. Epub 2014 Jun 23.
    View PubMed
  107. Sinicrope F, Foster NR, Sargent DJ, Thibodeau SN, Smyrk TC, O'Connell MJ, North Central Cancer Treatment Group. Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients. Cancer. 2010 Apr 1; 116(7):1691-8.
    View PubMed
  108. Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology 2015 Jan; 148 (1):77-87.e2 Epub 2014 Sept 30
    View PubMed
  109. Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology 2015 Jan; 148 (1):88-99 Epub 2014 Oct 08
    View PubMed
  110. Lee AM, Shi Q, Pavey E, Alberts SR, Sargent DJ, Sinicrope FA, Berenberg JL, Goldberg RM, Diasio RB. DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147). J Natl Cancer Inst. 2014 Dec; 106(12). Epub 2014 Nov 07.
    View PubMed
  111. Zaanan A, Bachet JB, Andre T, Sinicrope FA. Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in , and in Patients with Lymph Node-Positive Colon Cancer. Curr Colorectal Cancer Rep. 2014 Sep 1; 10(3):346-53.
    View PubMed
  112. Okamoto K , Zaanan A , Kawakami H , Huang S , Sinicrope FA . Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells. Mol Cancer Res 2015 Apr; 13 (4):659-69 Epub 2014 Dec 29
    View PubMed
  113. Zaanan A , Park JM , Tougeron D , Huang S , Wu TT , Foster NR , Sinicrope FA . Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. Int J Cancer 2015 Sep 15; 137 (6):1498-502 Epub 2015 Mar 09
    View PubMed
  114. Lynch PM , Burke CA , Phillips R , Morris JS , Slack R , Wang X , Liu J , Patterson S , Sinicrope FA , Rodriguez-Bigas MA , Half E , Bulow S , Latchford A , Clark S , Ross WA , Malone B , Hasson H , Richmond E , Hawk E . An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut 2016 Feb; 65 (2):286-95 Epub 2015 Mar 19
    View PubMed
  115. Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A. MiR-320e is a novel prognostic biomarker in colorectal cancer. Br J Cancer. 2015 Jun 30; 113(1):83-90. Epub 2015 Jun 02.
    View PubMed
  116. Kawakami H , Zaanan A , Sinicrope FA . Microsatellite instability testing and its role in the management of colorectal cancer. Curr Treat Options Oncol 2015 Jul; 16 (7):30
    View PubMed
  117. Campbell PT , Newton CC , Newcomb PA , Phipps AI , Ahnen DJ , Baron JA , Buchanan DD , Casey G , Cleary SP , Cotterchio M , Farris AB , Figueiredo JC , Gallinger S , Green RC , Haile RW , Hopper JL , Jenkins MA , Le Marchand L , Makar KW , McLaughlin JR , Potter JD , Renehan AG , Sinicrope FA , Thibodeau SN , Ulrich CM , Win AK , Lindor NM , Limburg PJ . AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev 2015 Aug; 24 (8):1229-38 Epub 2015 June 02
    View PubMed
  118. Alliance for Clinical Trials in Oncology, Yoon HH , Shi Q , Alberts SR , Goldberg RM , Thibodeau SN , Sargent DJ , Sinicrope FA . Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients. J Natl Cancer Inst 2015 Oct; 107 (10) Epub 2015 July 09
    View PubMed
  119. Zaanan A, Okamoto K, Kawakami H, Khazaie K, Huang S, Sinicrope FA. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism. J Biol Chem 2015 Sep 25; 290 (39):23838-49 Epub 2015 Aug 05
    View PubMed
  120. Alliance for Clinical Trials in Oncology, Sinicrope FA, Mahoney MR, Yoon HH, Smyrk TC, Thibodeau SN, Goldberg RM, Nelson GD, Sargent DJ, Alberts SR. Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance). Clin Cancer Res 2015 Dec 1; 21 (23):5294-304 Epub 2015 July 17
    View PubMed
  121. Lee AM , Shi Q , Alberts SR , Sargent DJ , Sinicrope FA , Berenberg JL , Grothey A , Polite B , Chan E , Gill S , Kahlenberg MS , Nair SG , Shields AF , Goldberg RM , Diasio RB . Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance). Pharmacogenet Genomics 2016 Mar; 26 (3):133-7
    View PubMed
  122. Kawakami H, Zaanan A, Sinicrope FA. Implications of mismatch repair-deficient status on management of early stage colorectal cancer. J Gastrointest Oncol 2015 Dec; 6 (6):676-84
    View PubMed
  123. Sinicrope FA , Okamoto K , Kasi PM , Kawakami H . Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer. Clin Gastroenterol Hepatol 2016 May; 14 (5):651-8 Epub 2016 Feb 09
    View PubMed
  124. Sweetser S , Jones A , Smyrk TC , Sinicrope FA . Sessile Serrated Polyps are Precursors of Colon Carcinomas With Deficient DNA Mismatch Repair. Clin Gastroenterol Hepatol 2016 Feb 17 [Epub ahead of print]
    View PubMed
  125. Ding X , Chaiteerakij R , Moser CD , Shaleh H , Boakye J , Chen G , Ndzengue A , Li Y , Zhou Y , Huang S , Sinicrope FA , Zou X , Thomas MB , Smith CD , Roberts LR . Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. Oncotarget 2016 Mar 4 Epub 2016 Mar 04
    View PubMed
  126. Alliance for Clinical Trials in Oncology, Phipps AI , Shi Q , Limburg PJ , Nelson GD , Sargent DJ , Sinicrope FA , Chan E , Gill S , Goldberg RM , Kahlenberg M , Nair S , Shields AF , Newcomb PA , Alberts SR . Alcohol consumption and colon cancer prognosis among participants in North Central Cancer Treatment Group phase III trial N0147. Int J Cancer 2016 Apr 8 Epub 2016 Apr 08
    View PubMed
  127. Yoon HH , Lewis MA , Foster NR , Sukov WR , Khan M , Sattler CA , Wiktor AE , Wu TT , Jenkins RB , Sinicrope FA . Central nervous system relapse in patients with untreated her2-positive esophageal or gastroesophageal junction adenocarcinoma. Int J Cancer 2016 May 20 [Epub ahead of print]
    View PubMed